EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microbiome depletion by broad-spectrum antibiotics does not influence demyelination and remyelination in cuprizone-treated mice

Rumi Murayama, Guilin Liu, Ming-Ming Zhao, Dan Xu, Ting-Ting Zhu, Yi Cai, Yong Yue, Hiroyuki Nakamura, Kenji Hashimoto

Pharmacology Biochemistry and Behavior · 2025

DOI: 10.1016/j.pbb.2024.173946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2025. Verfasst von Rumi Murayama und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan; Chiba University Center for…. Hauptthemen laut MEDLINE: Cuprizone, Demyelinating Diseases, Anti-Bacterial Agents, Remyelination. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Smoking Research Foundation, Japan Science and Technology Corporation, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Demyelination in the central nervous system (CNS) is a feature of various psychiatric and neurological disorders. Emerging evidence suggests that the gut-brain axis may play a crucial role in CNS demyelination. The cuprizone (CPZ) model, which involves the administration of CPZ-containing food pellets, is commonly used to study the effects of different compounds on CNS demyelination and subsequent remyelination. This study aimed to evaluate the impact of microbiome depletion, induced by an antibiotic cocktail (ABX), on demyelination in CPZ-treated mice and the subsequent remyelination following CPZ withdrawal. Our findings indicate that a chronic 4-week oral ABX regimen, administered both during and after a 6-week CPZ exposure, does not affect demyelination or remyelination in the brains of CPZ-treated mice. Specifically, ABX treatment for 2 weeks before and 2 weeks after CPZ exposure, in the final 4 weeks before sacrifice, and for 4 weeks post-CPZ withdrawal, did not significantly alter these processes compared to control mice receiving water instead of ABX. These results indicate that despite effective microbiome depletion, a 4-week oral ABX regimen does not influence demyelination or remyelination in the CPZ model. Thus, it is unlikely that gut microbiota depletion by ABX plays a significant role in these processes. However, further research is needed to fully understand the role of the host microbiome on CPZ-induced demyelination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CuprizoneDemyelinating DiseasesAnti-Bacterial AgentsRemyelinationGastrointestinal MicrobiomeMicrobiotaAnimalsMiceMaleMice, Inbred C57BLBrain

Stichwörter der Autor:innen

AntibioticCuprizoneDemyelinationGut microbiotaRemyelination

Substanzen

CuprizoneAnti-Bacterial Agents

Autor:innen und Institutionen

  • Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan; Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan.
  • Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan; Department of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao 266100, China.
  • Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan; Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
  • Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan; Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan.
  • Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.

Förderung

  • Smoking Research Foundation
  • Japan Science and Technology Corporation
  • Japan Science and Technology Agency

Zitieren

APA

Murayama, R., Liu, G., Zhao, M. M., Xu, D., Zhu, T. T., Cai, Y., Yue, Y., Nakamura, H., & Hashimoto, K. (2025). Microbiome depletion by broad-spectrum antibiotics does not influence demyelination and remyelination in cuprizone-treated mice. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2024.173946

Vancouver

Murayama R, Liu G, Zhao MM, Xu D, Zhu TT, Cai Y, et al. Microbiome depletion by broad-spectrum antibiotics does not influence demyelination and remyelination in cuprizone-treated mice. Pharmacology Biochemistry and Behavior. 2025. doi:10.1016/j.pbb.2024.173946

BibTeX
@article{Murayama2025,
  author = {Murayama, Rumi and Liu, Guilin and Zhao, Ming-Ming and Xu, Dan and Zhu, Ting-Ting and Cai, Yi and Yue, Yong and Nakamura, Hiroyuki and Hashimoto, Kenji},
  title = {Microbiome depletion by broad-spectrum antibiotics does not influence demyelination and remyelination in cuprizone-treated mice},
  journal = {Pharmacology Biochemistry and Behavior},
  year = {2025},
  doi = {10.1016/j.pbb.2024.173946}
}
Kostenlos starten →